Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Buy

Security Buy Sell Buy (1M) Sell (1M) Price Target price ▲ Potential
Omeros Corp. 2 4 0 0 €3.42 - -
Stratec SE 2 0 0 0 €41.90 - -
Viracta Therapeutics Inc. 2 0 2 0 €0.75 - -
Aldeyra Therapeutics Inc. 2 0 0 0 €3.88 - -
Clinica Baviera S.A. 2 0 0 0 €28.00 - -
Clinuvel Pharmaceuticals 1 0 0 0 €9.21 - -
Enlivex Therapeutics Ltd. 1 0 1 0 €1.49 - -
M1 Kliniken AG 2 0 0 0 €17.05 - -
Paul Hartmann AG 3 0 0 0 €202.00 - -
Drägerwerk AG & Co. KGaA ST 2 0 0 0 €44.70 - -
Bastide Le Confort 1 0 1 0 €18.30 - -
ShockWave Medical Inc 1 0 0 0 €307.00 - -
Pro-Dex Inc. 15 0 0 0 €16.40 - -
Trinity Biotech ADR 22 0 1 0 €0.41 - -
Vitrolife AB 3 0 0 0 €15.16 - -
Natural Alternat. 17 1 0 0 €5.70 - -
Lemaitre Vascular Inc 1 0 0 0 €61.50 - -
Immunogen Inc. 5 0 1 0 €28.97 - -
Virbac S.A. 1 0 0 0 €348.50 - -
Vericel Corp. 1 0 0 0 €44.40 - -
Brainstorm Cell 1 0 0 0 €0.37 - -
Adaptimmune Therapeutics PLC ADR 2 0 2 0 €1.10 €1.70 54.545%
Motus GI Holdings Inc. 2 0 0 0 €0.43 €2.33 443.991%
X4 Pharmaceuticals, Inc. 6 1 3 1 €1.07 €2.78 158.705%
ProQR Therapeutics N.V. 6 0 1 0 €1.87 €2.81 50.283%